Wave Life Sciences Officer Power of Attorney and Equity Holdings

This SEC Form 3 filing discloses the initial statement of beneficial ownership for Christopher I. Wright, Chief Medical Officer of Wave Life Sciences Ltd. The filing includes a power of attorney document authorizing company representatives and legal counsel to file Section 16 reports on Wright's behalf. Wright holds 45,625 ordinary shares through restricted share units that vest in four equal annual installments from February 2027 through February 2030. Additionally, he holds two stock option grants: 300,000 options with a $5.94 exercise price expiring May 2035, and 273,750 options with a $12.75 exercise price expiring February 2036. The power of attorney grants broad authority to company representatives and legal counsel to manage Wright's EDGAR account and file required Section 16 reports, remaining in effect until he is no longer required to file such reports.